Showing results (271-280 of 334) with videos related to

Sort By:
Pageof 34
The Science of the Total Environment|November 17, 2022
Generating environmental sampling and testing data for micro- and nanoplastics for use in life cycle impact assessmentCecilia Askham, Valentina H Pauna, Anne-Marie Boulay, et al.
BMJ Global Health|December 23, 2022
Associations between mental health and HIV status among sexual minority and heterosexual adolescents in NigeriaMorenike Oluwatoyin Folayan, Olakunle Oginni, Olanrewaju Ibikunle Ibigbami, et al.
The Australian and New Zealand Journal of Psychiatry|May 24, 2014
Psychological outcomes following the Victorian Black Saturday bushfiresRichard A Bryant, Elizabeth Waters, Lisa Gibbs, et al.
BMC Public Health|November 5, 2013
Beyond Bushfires: Community, Resilience and Recovery - a longitudinal mixed method study of the medium to long term impacts of bushfires on mental health and social connectednessLisa Gibbs, Elizabeth Waters, Richard A Bryant, et al.
British Journal of Haematology|September 1, 1996
Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis. Cooperative Study GroupsD Menache, D L Aronson, F Darr, et al.
Blood|May 24, 2003
Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusionJerry S Powell, Margaret V Ragni, Gilbert C White, et al.
The Journal of Biological Chemistry|August 19, 2011
Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulatorsScott J Lusher, Hans C A Raaijmakers, Diep Vu-Pham, et al.
BMC Oral Health|March 22, 2025
Systematic review and meta-analysis of the prevalence of oral cancer in NigeriaUcheoma Nwaozuru, Chisom Obiezu-Umeh, Somtochukwu Anthonia Uzodufa, et al.
Journal of Thrombosis and Haemostasis : JTH|September 27, 2006
Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter studyG Castaman, F Rodeghiero, A Tosetto, et al.
Blood|September 24, 2004
The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia BAmy D Shapiro, Jorge Di Paola, Alice Cohen, et al.
Pageof 34